Research ArticleDrug Delivery

An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics

See allHide authors and affiliations

Science Translational Medicine  14 Oct 2020:
Vol. 12, Issue 565, eabb0580
DOI: 10.1126/scitranslmed.abb0580

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine